-
-
-
-
-
-
-
PTC Therapeutics to Report Results from PIVOT-HD Long Term Extension Study
-
-
-
-
-
-
-
PTC Therapeutics reports Q4 Sephience revenue of $92.5 million
-
-
-
-
-
-
-
PTC Therapeutics (PTCT) PT Raised to $87 at BofA Securities
-
-
-
-
-
-
-
Citi Opens Upside 30d Catalyst Watch on PTC Therapeutics (PTCT)
-
-
-
-
-
-
-
Biotech sector Q1 earnings preview from RBC Capital Markets
-
-
-
-
-
-
-
PTC Therapeutics Provides Update on Commercial Performance and R&D Pipeline at 43rd Annual J.P. Morgan Healthcare Conference
-
-
-
-
-
-
-
JPMorgan on PTC Therapeutics (PTCT): 'Despite Notable Unknowns for Clinical & Regulatory Outlook, 12-mo PIVOT-HD Update Solidly Encouraging on All Fronts'
-
1,208,270 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

